UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIFF
7501
Firefly Neuroscience
AIFF
$17.9M
| $14.3K | ﹤0.01% |
2,308
+1,293
| +127% | +$9.62K |
|
7502
PUT
Vipshop
VIPS
$7.46B
| $14.3K | ﹤0.01% |
1,100
-509,900
| -100% | -$8.11M |
|
|
SIXD
7503
AllianzIM U.S. Equity 6 Month Buffer10 Jun/Dec ETF
SIXD
$396M
| $14.3K | ﹤0.01% |
+562
| New | +$14.2K |
|
|
AFBI
7504
DELISTED
Affinity Bancshares
AFBI
| $14.3K | ﹤0.01% |
673
+631
| +1,502% | +$11.4K |
|
7505
Envoy Medical
COCH
$52.7M
| $14.3K | ﹤0.01% |
+6,042
| New | +$22.5K |
|
7506
Rallybio
RLYB
$85.7M
| $14.3K | ﹤0.01% |
1,330
-2,504
| -65% | -$33.9K |
|
7507
Fractyl Health
GUTS
$109M
| $14.2K | ﹤0.01% |
+3,334
| New | +$21.5K |
|
|
LUNRW
7508
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
| $14.2K | ﹤0.01% |
20,930
+4,641
| +28% | +$4.91K |
|
7509
Benitec Biopharma
BNTC
$436M
| $14.2K | ﹤0.01% |
2,032
+1,520
| +297% | +$11.2K |
|
7510
Southland Holdings
SLND
$36.9M
| $14.2K | ﹤0.01% |
3,099
-1,247
| -29% | -$6.15K |
|
7511
flyExclusive
FLYX
$63.7M
| $14.2K | ﹤0.01% |
+3,520
| New | +$17.2K |
|
7512
ProShares UltraPro MidCap400
UMDD
$34M
| $14.2K | ﹤0.01% |
+588
| New | +$14.7K |
|
7513
VanEck China Bond ETF
CBON
$26.3M
| $14.1K | ﹤0.01% |
647
+629
| +3,494% | +$13.8K |
|
7514
Offerpad Solutions
OPAD
$21.8M
| $14.1K | ﹤0.01% |
319
+317
| +15,850% | +$19.7K |
|
|
VCSA
7515
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $14.1K | ﹤0.01% |
2,888
+2,835
| +5,349% | +$15.6K |
|
|
BLCN
7516
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
| $13.9K | ﹤0.01% |
534
-164
| -23% | -$4.29K |
|
7517
Amprius Technologies
AMPX
$1.66B
| $13.8K | ﹤0.01% |
10,862
+5,421
| +100% | +$8.85K |
|
7518
Main Thematic Innovation ETF
TMAT
$250M
| $13.8K | ﹤0.01% |
802
+797
| +15,940% | +$13.4K |
|
7519
MarketWise
MKTW
$56.3M
| $13.8K | ﹤0.01% |
594
-1,419
| -70% | -$41.8K |
|
7520
Copel
ELPC
$8.6B
| $13.8K | ﹤0.01% |
2,342
+2,290
| +4,404% | +$14.6K |
|
7521
Federated Hermes Total Return Bond ETF
FTRB
$598M
| $13.8K | ﹤0.01% |
+555
| New | +$13.7K |
|
|
SBXC
7522
DELISTED
SilverBox Corp III
SBXC
| $13.7K | ﹤0.01% |
+1,297
| New | +$13.7K |
|
7523
China SXT Pharmaceuticals
SXTC
$2.56M
| $13.7K | ﹤0.01% |
+10
| New | +$14.2K |
|
|
WBTN
7524
WEBTOON Entertainment Inc
WBTN
$1.26B
| $13.7K | ﹤0.01% |
+600
| New | +$13.7K |
|
7525
Alpha Architect Tail Risk ETF
CAOS
$718M
| $13.7K | ﹤0.01% |
+161
| New | +$13.6K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.